Crawford Investment Counsel’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Sell
7,808
-500
-6% -$18K ﹤0.01% 294
2026
Q1
$294K Sell
8,308
-98,380
-92% -$4M 0.01% 274
2025
Q4
$4.33M Sell
106,688
-217,310
-67% -$9.45M 0.07% 164
2025
Q3
$15.2M Buy
323,998
+36,186
+13% +$1.88M 0.25% 87
2025
Q2
$15M Buy
287,812
+2,232
+0.8% +$122K 0.26% 87
2025
Q1
$17.2M Buy
285,580
+32,970
+13% +$2.13M 0.31% 78
2024
Q4
$17.3M Buy
252,610
+6,669
+3% +$465K 0.31% 80
2024
Q3
$17.7M Buy
245,941
+40,434
+20% +$2.85M 0.3% 80
2024
Q2
$14.2M Buy
205,507
+3,025
+1% +$221K 0.27% 79
2024
Q1
$16.2M Buy
202,482
+60,374
+42% +$5.38M 0.3% 76
2023
Q4
$15.6M Buy
142,108
+1,685
+1% +$174K 0.31% 73
2023
Q3
$14.2M Buy
140,423
+3,350
+2% +$385K 0.31% 71
2023
Q2
$18.6M Sell
137,073
-21,033
-13% -$2.57M 0.38% 67
2023
Q1
$16.4M Buy
158,106
+11,900
+8% +$1.15M 0.35% 70
2022
Q4
$13M Sell
146,206
-1,343
-0.9% -$111K 0.28% 77
2022
Q3
$11.8M Buy
147,549
+9,458
+7% +$892K 0.28% 77
2022
Q2
$13.2M Buy
138,091
+13,936
+11% +$1.67M 0.29% 79
2022
Q1
$18.4M Sell
124,155
-3,025
-2% -$422K 0.36% 68
2021
Q4
$18M Sell
127,180
-513
-0.4% -$72.7K 0.34% 65
2021
Q3
$16.7M Buy
127,693
+10,083
+9% +$1.32M 0.34% 65
2021
Q2
$16.2M Buy
117,610
+10,780
+10% +$1.48M 0.33% 67
2021
Q1
$14M Buy
106,830
+58,185
+120% +$7M 0.31% 71
2020
Q4
$5.45M Buy
48,645
+2,385
+5% +$226K 0.13% 102
2020
Q3
$3.64M Buy
46,260
+8,850
+24% +$722K 0.1% 115
2020
Q2
$2.69M Buy
37,410
+30,500
+441% +$2.12M 0.08% 134
2020
Q1
$396K Buy
+6,910
New +$637K 0.01% 212

Other funds holding CNMD

Crawford Investment Counsel's CNMD Position: Q2 2026 in Review

Crawford Investment Counsel reduced its CONMED (CNMD) stake by 6% in Q2 2026, selling an estimated $18K and leaving 7,808 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Crawford Investment Counsel first reported a position in CNMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $18.6M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Crawford Investment Counsel held 7,808 shares of CONMED worth $256K as of Q2 2026.
  • Crawford Investment Counsel sold 500 CONMED shares in Q2 2026, an estimated $18K.
  • CONMED made up ﹤0.01% of Crawford Investment Counsel's portfolio in Q2 2026, its #294 holding.
  • Crawford Investment Counsel first reported a position in CONMED in Q1 2020 and has held it in 26 quarters since.
  • Crawford Investment Counsel's CONMED position peaked at $18.6M in Q2 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Crawford Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.